Trial site
Niigata
- 9running trials
- 6closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy3 trials
- Multiple sclerosis3 trials
- Childhood cancers2 trials
- Lung cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Metastatic breast cancer1 trial
- Neuroendocrine tumours1 trial
- Vitiligo1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Status
- Active, not recruiting7 trials
- Completed6 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals15 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Active, not recruiting
Recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Completed
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026